NGL Fine-Chem Limited (NSE:NGLFINE)
India · Delayed Price · Currency is INR 1,224.40
-36.20 (-2.87%)
Aug 6, 2025, 11:26 AM IST
Lions Gate Entertainment Market Cap
NGL Fine-Chem has a market cap or net worth of 7.84 billion as of August 5, 2025. Its market cap has decreased by -50.56% in one year.
Market Cap
7.84B
Enterprise Value
7.96B
Revenue
3.82B
Ranking
n/a
PE Ratio
37.09
Stock Price
$1,224.40
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 7.84B, an increase of 9,655.75%. That is a compound annual growth rate of 24.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 7.84B | -29.47% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | 6.96B | 165.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,910.20B |
| Divi's Laboratories | 1,688.78B |
| Cipla | 1,213.89B |
| Mankind Pharma | 1,059.19B |
| Apollo Hospitals Enterprise | 1,057.03B |
| Zydus Lifesciences | 954.97B |
| Fortis Healthcare | 648.70B |
| Aurobindo Pharma | 627.15B |